Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 42.20
0.00 (0.00%)
Feb 11, 2026, 9:00 AM CET
Biosergen AB Revenue
Revenue (ttm)
2.09M
Revenue Growth
n/a
P/S Ratio
47.46
Revenue / Employee
2.09M
Employees
1
Market Cap
99.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2019 | 1.31M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IRLAB Therapeutics AB | 85.56M |
| Alligator Bioscience AB | 46.22M |
| Alzinova AB | 26.12M |
| Scandinavian ChemoTech AB | 11.68M |
| Biovica International AB | 9.89M |
| Spago Nanomedical AB | 5.84M |
| OncoZenge AB | 2.78M |
| Simris Group AB (PUBL) | 2.30M |